SNØTINDENE AS • 994769596 • Oslo • Financial service activities, except insurance and pension funding

This website uses cookies to enhance the user experience.

Banking and insurance

/ Financial fund

/ 64.308 Captive investment companies

SNØTINDENE AS

Keywords

placementsecurities

Organization

CEO: ER
Erik Rosen1964
Chairman of the board: BK
Birgitte Kolrud1969
Years since formation: 16 years; since Nov 14, 2009
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 40,000; 1 share class
Total number of shareholders: 2; persons

Financials

Annual total result 2024: 1,022,629; NOK
Total equity 2024: 1,130,569; NOK

Last update: May 28, 2025

Management

Management / administration

Name	Role	Shares
ER Erik Rosen 1964	Managing Director/CEO	50 % directly

Board

Name	Role	Shares
BK Birgitte Kolrud 1969	Chairman	50 % directly
ER Erik Rosen 1964	Alternate Member	50 % directly

Others

Name	Role	Shares
T TRIO REGNSKAP AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
ER Erik Rosen 1964	Managing Director/CEO, Alternate Member	50 % directly
BK Birgitte Kolrud 1969	Chairman	50 % directly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
BK Birgitte Kolrud 1969	Ordinary shares	20,000	50 %
ER Erik Rosen 1964	Ordinary shares	20,000	50 %

Shares owned by the SNØTINDENE AS

Name	Share class	Total number of shares	Share
S SENSE BIOPHARMA AS	Ordinary shares	934	1.16 %
P POLYPURE AS	Ordinary shares	3,793	0.31 %
A AMICOAT AS	NO0010799679	25,752	0.07 %
R R-VENTURE AS	NO0010279474	31,000	0.05 %
P PHARMA HOLDINGS AS	NO0010797350	15	< 0.01 %
P PHARMASUM THERAPEUTICS AS	Ordinary shares	71	< 0.01 %
L LYTIX BIOPHARMA AS	NO0010405780	1,280	< 0.01 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	0	0	0	0
Annual Total Result	1,022,629	-130,344	68,018	19,110
Total assets	1,318,946	268,429	388,773	316,843
Total liabilities	188,376	160,489	150,489	146,576
Total equity	1,130,569	107,941	238,285	170,267

P&L

Year	2024	2023	2022	2021
Total operating income	0	0	0	0
Total operating costs	9,691	10,327	11,239	10,541
Operating result	-9,691	-10,327	-11,239	-10,541
Financial income/costs	1,032,320	-120,017	79,257	29,651
Profit before tax	1,022,629	-130,344	68,018	19,110
Total tax & extraordinary income/cost	0	0	0	0
Annual Total Result	1,022,629	-130,344	68,018	19,110

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	0	0	0	0
Total current assets	1,318,946	268,429	388,773	316,843
Total assets	1,318,946	268,429	388,773	316,843
Short term debt	188,376	160,489	150,489	146,576
Long term debt	0	0	0	0
Total liabilities	188,376	160,489	150,489	146,576
Contributed capital	400,000	400,000	400,000	400,000
Retained earnings	730,569	-292,059	-161,715	-229,733
Total equity	1,130,569	107,941	238,285	170,267
Total equity and liabilities	1,318,946	268,429	388,773	316,843

Classification

Category

Banking and insurance

/ Financial fund

Type of organization

Limited company

Standard industrial classification

K

Main industrial area

Financial and insurance activities

64

Activity

Financial service activities, except insurance and pension funding

64.3

Main industrial group

Trusts, funds and similar financial entities

64.30

Industrial group

Trusts, funds and similar financial entities

64.308

Industrial group

Captive investment companies